|
Thursday 16th January 2014 |
Text too small? |
Rakon, whose shares have halved in the past year, plans to close its UK factory as soon as this year, taking a provision that would widen its full-year loss.
The maker of quartz crystals used in navigation systems and smart phones has advised workers at its Lincoln plant that it intends to close the facility, leaving only a research and development centre in the UK.
A board review showed "duplicate overhead structures and manufacturing capability exists between the Lincoln and New Zealand operations," the Auckland-based company said in a statement. "The proposal is for a full closure of the plant with the manufacturing of products to be shifted to Rakon's New Zealand plant."
Should the closure be completed in the year ending March 31, Rakon expects to report a full-year loss of between $55 million to $59 million, compared with an earlier forecast of a loss of $54 million.
Rakon's shares fell 2.6 percent to 18.5 cents, having traded as high as 38 cents a year ago and down from as high as $5.35 in November 2007.
Last year the company quit its Chinese operations to reduce debt. The company said today that its announcement on the UK factory won't delay its target of reducing bank debt below $12 million by March 31.
Rakon also reiterated its target of a return to positive earnings in 2015, with earnings before interest, tax, depreciation and amortisation of between $10 and $15 million. On an EBITDA basis the company is forecasting a loss of between $5 to $8 million in the current year, a deterioration from its previous guidance of between a loss of $3 million and break even.
BusinessDesk.co.nz
No comments yet
IKE - FY26 Financial Results
Chorus submits 2025 fibre regulatory report
SPG - FY26 Annual Results
PYS - PaySauce FY26 Full Year Result and Annual Report
IFT - Infratil Full Year Results for the year ended 31 March 2026
May 27th Morning Report
RYM - FY26 marks significant year of progress
FPH reports strong revenue and profit growth for FY26
IFT - Infratil Full Year Results for the year ended 31 March 2026
PEB - Advancing Medicare Coverage Goals; Cost Contained